1 Safe-and-Steady Stock to Target This Week and 2 We Avoid

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Luckily for you, StockStory helps you navigate which companies are truly worth holding. Keeping that in mind, here is one low-volatility stock that could offer consistent gains and two stuck in limbo.

Two Stocks to Sell:

Harley-Davidson (HOG)

Rolling One-Year Beta: 0.81

Founded in 1903, Harley-Davidson (NYSE:HOG) is an American motorcycle manufacturer known for its heavyweight motorcycles designed for cruising on highways.

Why Does HOG Give Us Pause?

1. Performance surrounding its motorcycles sold has lagged its peers
2. Diminishing returns on capital suggest its earlier profit pools are drying up
3. High net-debt-to-EBITDA ratio of 19× increases the risk of forced asset sales or dilutive financing if operational performance weakens

Harley-Davidson is trading at $24.20 per share, or 8.5x forward P/E. Dive into our free research report to see why there are better opportunities than HOG.

Pfizer (PFE)

Rolling One-Year Beta: 0.41

With roots dating back to 1849 when two German immigrants opened a fine chemicals business in Brooklyn, Pfizer (NYSE:PFE) is a global biopharmaceutical company that discovers, develops, manufactures, and sells medicines and vaccines for a wide range of diseases and conditions.

Why Do We Think Twice About PFE?

1. Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
2. Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 17.4 percentage points
3. Diminishing returns on capital suggest its earlier profit pools are drying up

At $24.28 per share, Pfizer trades at 8.4x forward P/E. Read our free research report to see why you should think twice about including PFE in your portfolio.

One Stock to Watch:

Cigna (CI)

Rolling One-Year Beta: 0.31

With roots dating back to 1792 and serving millions of customers across the globe, The Cigna Group (NYSE:CI) provides healthcare services through its Evernorth Health Services and Cigna Healthcare segments, offering pharmacy benefits, specialty care, and medical plans.

Why Does CI Stand Out?

1. Annual revenue growth of 18.7% over the past two years was outstanding, reflecting market share gains this cycle
2. Massive revenue base of $262 billion gives it meaningful leverage when negotiating reimbursement rates
3. Earnings growth was above the peer group average over the last five years as its EPS compounded at 7.7% annually

Cigna’s stock price of $271.50 implies a valuation ratio of 8.5x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.

High-Quality Stocks for All Market Conditions

Trump’s April 2024 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.